Future4care, one year at the heart of the e-health revolution
Paris (France), May 16th, 2022 - In June 2021, Sanofi, Capgemini, Generali and Orange announced the creation of Future4care. One year after its launch, the inauguration of Future4care today provides an opportunity to take stock of its successes and its ambition to accelerate the development of e-health solutions.
Published on May 18th, 2022 at 11:16 am
First step taken: the launch of the gas pedal. In December 2021, after a selection phase, 20 digital healthcare startups joined Future4care to make up its first class.
In February 2022, their support began. A personalized program was co-constructed with each of them.
In April 2022, Future4care launched its second call for applications, with plans to recruit a new class to complement the first one already in place.
The second milestone reached was the launch of the institute, with a day of conferences focusing on ethics. The Institute's vocation is to acculturate, federate and move the lines. It has set up a Scientific and Ethical Advisory Board, comprising leading figures from a wide range of disciplines and chaired by Professor Olivier Guérin. This year, the institute will focus its initial work on the impact of digital technology on personalized medicine and remote access to care.
In parallel with the launch of its activities, Future4care has federated an initial circle of industrial partners: Be-Ys, Biocodex, Alira Health and UCB have joined the ecosystem. Other companies will soon follow to give Future4care its full European dimension.
To symbolize these initial successes, Future4care is inaugurating its premises and digital platform on May 16th, 2022, entirely designed to foster ideation, collaboration and, more broadly, innovation.
Agnès De Leersnyder, Managing Director of Future4care, comments: “Together with the Future4care team and the committed collaborators of our founders, we are very proud of how far we have come in the last 12 months. Today, over a hundred entrepreneurs, experts, researchers and other healthcare professionals have joined us. The adventure is just starting. We look forward to seeing you in a year's time.”
APPENDIX
Supported startups
ArcaScience Al
CEO: Romain Clément.
First solution to combine a biomedical data fusion tool with a specialized, tailor-made AI development framework, multiplying data profitability by a factor of 4.
Bbalance
Co-founders: Jean-Marc Druesne (CEO of Bbalance and CMO of Baracoda) and Gauthier de Rouzé (CTO)
Baracoda offers BBalance, a bath mat equipped with patented pressure measurement technology for daily monitoring of the body's state of health. It comes with a personalized coaching program.
Blazar
Founder: Dora Carrasco Sabino
Blazar predicts response to onco-immunotherapy by deploying statistical and deep learning methods on clinical data, improving outcomes for patients.
Bliss Digital Therapeutics
https://www.bliss-solution.com/
President: Mélanie Péron
Bliss Digital Therapeutics offers VR goggles/headsets to reduce pain in patients with chronic diseases and/or during medical interventions.
Bodyo
Founder: Patrice Coutard
Bodyo creates innovative telehealth devices that improve the health and well-being of individuals by preventing the onset of chronic diseases through engaging prevention programs accessible to all via self-monitoring and telemedicine stations.
Casis
https://www.casis.fr/fr/casis-cardiac-simulation-imaging-software/
Founder: Jean-Joseph Christophe
Casis offers cardiovascular imaging software to improve and reinforce clinical diagnosis. The use of deep learning algorithms, based on the QIR suite, to help healthcare professionals interpret and understand cardiovascular MRI and CT scans. The interface, in various languages, which also includes a small training module.
Hoppen
Founders: Sébastien Duré and Matthieu Mailédant
Hoppen is a project for a phygital platform to accompany patients during their hospitalization, with personalized services tailored to each patient to help them through every stage of their stay. The initial observation was that nursing staff spend only 30% of their time with the patient, the rest in the corridors + 7 km in the corridor. The result of the experiment was that they spent 55% of their time with the card. Their solution is to digitize all actions that take place in the room: meals / room cleaning / care and life in the building.
i-virtual
https://www.caducy.com/fr/i-virtual/
CEO : Gaël Constancin
i-Virtual is a start-up specialized in image and data processing for everyday health and well-being, transforming any camera into a medical device. Caducy is the first European system for non-contact measurement of vital parameters using a camera.
Juisci
Co-founders: Robin Roumengas (CEO) and David Luu (CMO)
Edtech/continuing medical education combining AI (proprietary algorithms) and deeptech with a SAAS solution. Its aim is to democratize medical education.
It will also become a platform for peer-to-peer exchange. Enable HCPs to receive instant, live and reliable information in summary, visual and personalized format.
Kapcode
Founders: Dr Stéphane Schück, Nathalie Texier and Adel Mebarki
Kapcode develops E-Detect, the first tool to take into account the patient's voice in real time during the care process, using artificial intelligence and natural language processing methods.
Knok
Co-founders: José Bastos (CEO) and Joao Magalhaes (CTO)
Knok is a world leader in integrated care video platform software. Knok works with leading hospitals, healthcare organizations and insurance companies to improve all aspects of patient care by providing an easy-to-use platform for doctors and patients.
MaPatho
Founders: Axelle Ayad N'Ciri and Pierre-Emmanuel Obeniche
MaPatho makes it possible to find a trusted specialist and quality information can sometimes be a real uphill battle. MaPatho is a 4P platform designed to improve patients' daily lives.
Medvir
Founder: Dr Loïc Etienne
Medvir has developed a solution that uses symptom analysis to identify, in primary care, whether there is a need to go to the emergency room (hearing weak signals).
PK Vitality
https://www.pkvitality.com/fr/
Co-founders: Luc Priérart (CEO) and Minh Lê (MD)
PK Vitality develops K'Watch, the first Continuous Glucose Monitor in the form of a connected watch, enabling simple, pain-free monitoring of blood glucose levels, with no stigma for diabetics.
Remedee
Co-founders: Jacques Husser (Chairman), David Crouzier (CEO, CSO), Gilles Litman (CBO) and Michael Foerster (CTO)
Thanks to the first endorphin stimulator combined with a digital service platform (wristband with sensors), Remedee is a device for analyzing health data for patients suffering from chronic pain (endometriosis in particular), then stimulating endorphin secretion to treat these same patients, depending on the data collected.
Rofim
Chairman and founder: Dr David Bensoussan
Rofim is a collaborative diagnostics and telemedicine platform enabling tele-expertise, RCP, tele-consultation and secure communication.
Rofim is built around three complementary areas of expertise: medical, technical and strategic.
SentinHealth
Founders: Stéphanie de Marco (General Manager), Thibault Parmentier (Deputy General Manager)
SentinHealth is the first refundable solution for patients with severe heart failure and loss of autonomy, who need daily or lifelong monitoring. SentinHealth is based on a subcutaneous implant that enables daily monitoring of heart/lung/temperature and position parameters at home, and trigerring action.
Trayvisor
Diane Buisson (Business Development Manager), Alberto Pimentel (CTO)
Trayvisor is an innovative solution that analyzes trays before and after meals, to systematize the recording of patients' food intake.
The technology is based on visual recognition and analysis of foodstuffs from a photograph.
Trayvisor enables healthcare professionals to rapidly categorize the risk of undernutrition in hospitalized patients and residents of medical-social establishments.
Wefight
Co-founders: Benoît Brouard (CEO) and Pierre Nectoux (CTO)
Wefight develops Vik, the virtual companion for patients with cancer and chronic illnesses. Available in 12 countries, Vik accompanies +350,000 patients throughout their treatment.
WhiteLab Genomics
Founders: David Del Bourgo (CEO), Dr. Julien Cottineau (CSO)
WhiteLab Genomics has developed an Artificial Intelligence platform to accelerate the development of genomic therapies based on DNA or RNA. The company's flagship applications are the discovery of new biomarkers, the design of payloads and genetic vectors. Founded in 2019, the company already has several customers in France and the United States, including large American biotech consortia.
Our partners
Be ys
In January 2022, be ys, the expert in high technologies for digital trust and data governance applied to insurance and healthcare, became Future4care's first industrial member.
This collaboration expands the Future4care ecosystem to support and accelerate the development of French and European startups offering digital healthcare solutions.
be ys is a service management technology platform for a wide range of players in the insurance, healthcare and personal protection sectors. The company develops differentiating services from a position of absolute neutrality and integrity, protecting its customers' data assets at the cutting edge of today's technologies. be ys is also involved in crucial areas such as payment security and patient transactions, the sovereign cloud, and the processing and hosting of sensitive and personal data in highly secure data centers. The be ys group currently employs 3,200 people worldwide, 460 of whom are based in France.
Biocodex
In April 2022, Biocodex, a pioneer and major international player in the field of microbiota and women's health, joined Future4care as a new industrial member.
The arrival of this company, with over 1,600 employees, reinforces the multi-disciplinary approach sought by Future4care's founders.
For several years now, Biocodex has been investing in start-ups focusing on microbiota, its main area of expertise. The partnership with Future4Care will enable Biocodex to accelerate its development in digital health and take its place in this ecosystem of excellence.
Future4care and Biocodex share the same convictions, first and foremost that of bringing together the players in the ecosystem to make possible the innovations that will shape tomorrow's healthcare, for the benefit of the patient. By joining the initiative, Biocodex will contribute to the "factoring" of solutions that address the issues of sovereignty over healthcare data on a European scale, and the question of how to regulate their use.
Alira Health
Alira Health is a healthcare consulting company based in Europe and the United States, offering a continuum of services built around clinical research, regulatory affairs, market access, strategy & organization, and transaction teams to support its customers at every stage of product development & commercialization. Our patient engagement, real-world evidence and data analytics departments provide innovative patient and data-related services. Finally, our digital solutions are deployed today in clinical trials - both traditional and decentralized (eCRF, ePRO/eCOA, eDiary) - and in real life (remote monitoring and telemedicine, PSP and digital treatment/DTx).
Composition of the Scientific and Ethical Committee
- Lise Arena
- Karim Benchenane
- Jean-Marc Bereder
- Sophie Bernard
- Michel Caillol
- Fabrice Denis
- Emmanuel Fraysse
- David Gruson
- Charles Guepratte
- Enguerrand Habran
- Emmanuel Hirsch
- Franck Lebrin
- Victoire Leroy
- Jean-Jacques Machuret
- Alexandre Malouvier
- Julie Martinez-Tonon
- Charbel Massaad
- Patrick Nataf
- Philippe Nghe
- Frédéric Prate
- Juliette Raffort-Lareyre
About
About Sanofi
Sanofi's vocation is to help people facing health problems. As a global biopharmaceutical company specializing in human health, we prevent diseases with our vaccines and offer innovative treatments. We support people suffering from rare diseases, as well as the millions of people suffering from chronic illnesses.
Sanofi and its more than 100,000 employees in 100 countries transform scientific innovation into healthcare solutions worldwide.
Sanofi, Empowering Life. More information on www.sanofi.fr
About Capgemini
Capgemini is a responsible, multicultural global leader, with 270,000 people in nearly 50 countries. A strategic partner to companies transforming their businesses by harnessing the power of technology, the Group is guided every day by its raison d'être: to unleash human energies through technology for an inclusive and sustainable future. With more than 50 years' of experience and an extensive industry expertise, Capgemini is recognized by its clients for meeting all their needs, from strategy and design to operations management, leveraging innovations in the ever-evolving fields of cloud, data, Artificial Intelligence, connectivity, software, digital engineering and platforms. The Group achieved sales of 16 billion euros in 2020.
Get The Future You Want | www.capgemini.com
About Generali France
Generali France is one of France's leading insurers and asset managers, with sales of 15.5 billion euros in 2021. It offers its 7.8 million individual, professional and corporate customers a comprehensive range of insurance (health, personal protection, assistance, property and liability), savings and asset management solutions. Established in France since 1832, Generali France relies on the know-how and expertise of its 9,000 employees, tied agents and branch staff, as well as its networks of brokers and intermediaries. Its vision: to be the partner of its customers and distributors throughout their lives. As a committed company, Generali France places sustainability at the heart of its strategy, with the ambition of being a responsible insurer, investor, employer and player, in particular through its foundation The Human Safety Net.
More information on https://www.generali.fr
About the Generali Group
Generali is one of the largest international insurance and asset management groups. Founded in 1831, it operates in 50 countries, with sales of 75.8 billion euros in 2021. With more than 75,000 employees serving 67 million customers worldwide, the Group holds a leading position in Europe and a growing one in Asia and Latin America. Generali's ambition is to be its customers' partner throughout their lives, offering innovative and personalized solutions and drawing on an unrivalled distribution network, a first-rate customer experience and its global digitalized distribution capabilities. The Group has fully integrated sustainable development into all its strategic choices, with the aim of creating value for all stakeholders while building a fairer, more resilient society.
More information on http://www.generali.com
About Orange
Orange is one of the world's leading telecommunications operators, with sales of 42.5 billion euros in 2021 and 137,000 employees at March 31, 2022, including 76,000 in France. The Group served 278 million customers on March 31, 2022, including 232 million mobile customers and 24 million fixed broadband customers. The Group is present in 26 countries.
Orange is also one of the world's leading providers of telecommunication services to multinational companies under the Orange Business Services brand. In December 2019, the Group presented its new "Engage 2025" strategic plan, which, guided by social and environmental exemplarity, aims to reinvent its business as an operator. While accelerating in growth-generating territories and areas and placing data and AI at the heart of its innovation model, the Group intends to be an attractive and responsible employer, suited to emerging professions.
Orange is listed on Euronext Paris (symbol ORA) and on the New York Stock Exchange (symbol ORAN). For more information (on the web and your mobile): www.orange.com, www.orange-business.com or to follow us on Twitter: @presseorange.
Orange and any other Orange products or services mentioned in this press release are trademarks owned by Orange or Orange Brand Services Limited.
